Disclosures: Young Kul Jung: Nothing to Disclose, Hyung Joon Yim: Nothing to Disclose, Taehyung Kim: Nothing to Disclose, Do Seon Song: Nothing to Disclose, Eileen Yoon: Nothing to Disclose, Sung Won Lee: Nothing to Disclose, Ki Tae Suk: Nothing to Disclose, JAE YOUNG JANG: Nothing to Disclose, Moon Young Kim: Nothing to Disclose, Sang Gyune Kim: Nothing to Disclose, Soung Won Jeong: Nothing to Disclose, Jung Gil Park: Nothing to Disclose, Won Kim: Nothing to Disclose, Sung Eun Kim: Nothing to Disclose, Ji Won Park: Nothing to Disclose, Dong Joon Kim: Nothing to Disclose 684 CLINICAL CHARACTERISTICS OF RECURRENT BACTEREMIA IN END-STAGE LIVER DISEASE: 10-YEAR EXPERIENCE IN A SINGLE CENTER IN SOUTHWEST CHINA Min Luo 1 Huan Deng 1 Lingyu Song 2 Yaping Shi 3 Hua He 1 Dachuan Cai 4 Xiaofeng Shi 1 Yongjian Liu 2 , 1 The Second Affiliated Hospital, Chongqing Medical University, 2 The Second Affiliated Hospital of Chongqing Medical University, 3 Children's Hospital of Yongchuan District, 4 Chongqing Medical University Background: Several factors contribute to the susceptibility to bacterial infections in patients with end-stage liver disease (ESLD), such as immune dysfunction, alterations and excessive growth of gut microbiome and bacterial translocation
Methylcobalamin (CH3-B12) is equivalent physiologically to vitamin B12, and can be used to prevent or treat pathology arising from a lack of vitamin B12 (vitamin B12 deficiency), such as pernicious anemia
"Screening, early detection, education, and trends for melanoma: current status (2007-2013) and future directions: Part I
doi: 10.11983/CBB19028
